Company Jiangsu Recbio Technology Co., Ltd.

2179

CNE1000057K9

Pharmaceuticals

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Biopharmaceuticals

End-of-day quote Hong Kong S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
9.2 ^CNY	+0.11%		+0.77%	-15.29%

Mar. 27	Jiangsu Recbio Technology Co., Ltd. and Shanghai Rongsheng Biotech Co.,Ltd. Sign Strategic Cooperation Agreement on the New Adjuvant Vaccine Project	CI
Mar. 21	Jiangsu Recbio Technology's Loss Narrows in 2023	MT

Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.

Number of employees: 472

Managers	Title	Age	Since
Yong Liu CEO	Chief Executive Officer	51	12-05-17
Qing Qing Chen DFI	Director of Finance/CFO	41	-
Jian Hui Zhang CTO	Chief Tech/Sci/R&D Officer	-	-
Kun Xue Hong CTO	Chief Tech/Sci/R&D Officer	59	21-05-08
Bu Li BRD	Director/Board Member	48	21-03-26
Jian Ping Chen BRD	Director/Board Member	46	20-11-01
Lei Zhou AUD	Comptroller/Controller/Auditor	38	-

Members of the board	Title	Age	Since
Ming Fai Yuen BRD	Director/Board Member	73	21-05-08
Li Jun Xia BRD	Director/Board Member	48	21-06-27
Hong Bin Zhou BRD	Director/Board Member	51	20-11-01
Ran Ting Qian BRD	Director/Board Member	49	21-05-24
Wei Wei Qiao CHM	Chairman	37	21-05-08
Yong Liu CEO	Chief Executive Officer	51	12-05-17
Jian Ping Chen BRD	Director/Board Member	46	20-11-01
Bu Li BRD	Director/Board Member	48	21-03-26
Qing Qing Chen DFI	Director of Finance/CFO	41	-
Fei Zhou Wang BRD	Director/Board Member	57	22-06-16

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	316,138,689	0	3,811,000 ( 1.205 %)	22.40 %
Stock B	1	12,000,000	0	0
Stock C	1	154,824,311	108,198,078 ( 69.88 %)	0

Name	Equities	%	Valuation
Shanghai Chaorui Medical Technology LLP 9.462 %	29,912,024	9.462 %	37 M ¥
Legend Capital Co. Ltd. 6.723 %	21,254,565	6.723 %	27 M ¥
Yong Liu 6.553 %	20,715,905	6.553 %	26 M ¥
Jiangsu Cmb Modern Industry Equity Invt Fund Phase I LP 6.467 %	20,446,160	6.467 %	26 M ¥
LYFE Niagara River Ltd. 5.742 %	18,151,700	5.742 %	23 M ¥
Shenzhen Oriental Fortune Capital Investment Mgmt Co. Ltd. 5.044 %	15,946,630	5.044 %	20 M ¥
Yangtze River (Hong Kong) Co., Ltd. 3.991 %	12,618,500	3.991 %	16 M ¥
Hongshan 3.865 %	12,219,040	3.865 %	15 M ¥
Lake Bleu Capital (Hong Kong) Ltd. 3.574 %	11,300,000	3.574 %	14 M ¥
Hong Yan Liu 0.7783 %	2,460,400	0.7783 %	3 M ¥

Name	Equities	%	Valuation
Yong Liu 18.61 %	70,224,638	18.61 %	88 M ¥
Shenzhen Sequoia Yuechen Investment Partnership LP 2.375 %	8,962,500	2.375 %	11 M ¥
Shanghai Chaorui Medical Technology LLP 1.982 %	7,478,006	1.982 %	9 M ¥
Legend Capital Co. Ltd. 1.878 %	7,084,855	1.878 %	9 M ¥
Hong Yan Liu 0.1630 %	615,100	0.1630 %	770 204 ¥

Name	Equities	%	Valuation
GIC Pte Ltd. (Investment Management) 100.00 %	12,000,000	100.00 %	15 M ¥

Jiangsu Recbio Technology Co., Ltd.

Medical High-tech District No. 888 Yaocheng Avenue

215300, Taizhou

http://www.recbio.cn

address Jiangsu Recbio Technology Co., Ltd.(2179)

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

8.523 CNY

Average target price

13.79 CNY

Spread / Average Target

+61.77%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
JIANGSU RECBIO TECHNOLOGY CO., LTD.	-15.29%	563M
CSL LIMITED	-3.79%	87.06B
SAMSUNG BIOLOGICS CO.,LTD.	+1.45%	40.25B
BIOGEN INC.	-15.94%	31.09B
UCB	+52.66%	24.74B
BIOMARIN PHARMACEUTICAL INC.	-14.50%	15.91B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	11.96B
INCYTE CORPORATION	-14.38%	11.92B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61B
SWEDISH ORPHAN BIOVITRUM AB	+4.87%	8.73B

Biopharmaceuticals